Highmark April 2026 Formulary Overview: Prescription Drug Management Updates Please see key updates from Highmarks April 2026 Formulary Overview and recent prescription drug management changes
But preclinical results do not guarantee equivalent outcomes in humans, and no responsible review of this compound should suggest otherwise
Reported effects include: Local discomfort at the injection site
It has examined current adoption data showing that while ePA is not yet universal, its use is expanding rapidly under industry and regulatory pressure
As a result, the ratio of the two detection levels can be used to determine if rhGH was administered within 36 hours but it is recommended that sampling time should be less than 24 hours for increased accuracy (Pope et al., 2014, Baumann, 2012)
Though not definitively established, this association is not unexpected: prescribing information for agents like liraglutide, exenatide, and dulaglutide has long included warnings or contraindications in people with prior pancreatitis or gallstone disease [24, 25]
